Myriad CEO Mark Capone notes that the current healthcare system in the U.S. is one of the most effective in the world, but also one of the most inefficient. Molecular diagnostics can help deliver greater efficiency, as well as provide important information for consumers to use in making decisions about their own healthcare.

Investor Day

August 11, 2022